MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

Not Applicable

Completed

Conditions: Alzheimer's Disease Prevention

Interventions: Behavioral: Aerobic vs. Non-Aerobic exercise

First Posted Date: 2013-04-18

Last Posted Date: 2019-03-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT01834716

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions

Phase 2

Completed

Conditions: Constipation

Interventions: Other: Placebo
Drug: Alfuzosin

First Posted Date: 2013-04-18

Last Posted Date: 2019-01-29

Lead Sponsor: Mayo Clinic

Target Recruit Count: 74

Registration Number: NCT01834729

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement

Terminated

Conditions: Normal Pressure Hydrocephalus Patients

Interventions: Diagnostic Test: PET scan

First Posted Date: 2013-04-18

Last Posted Date: 2022-02-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2

Registration Number: NCT01834625

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Physical Activity and Health Outcomes

Phase 2

Completed

Conditions: Obese
Overweight

Interventions: Behavioral: Usual Care
Behavioral: Self-Exercise

First Posted Date: 2013-04-17

Last Posted Date: 2016-01-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 130

Registration Number: NCT01833507

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients

Completed

Conditions: Urinary Tract Infection

First Posted Date: 2013-04-17

Last Posted Date: 2016-04-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 129

Registration Number: NCT01834391

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

Phase 4

Completed

Conditions: Obesity

Interventions: Drug: Placebo
Drug: Phentermine-Topiramate ER

First Posted Date: 2013-04-17

Last Posted Date: 2015-02-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT01834404

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Early Phase 1

Completed

Conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)
Extraosseous Ewing Sarcoma
Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Ewing Sarcoma of Bone
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

Interventions: Drug: fluorine F 18 fluorothymidine
Radiation: fludeoxyglucose F 18
Procedure: positron emission tomography
Procedure: diffusion-weighted magnetic resonance imaging
Other: laboratory biomarker analysis

First Posted Date: 2013-04-08

Last Posted Date: 2017-11-20

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01825902

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

CYP2C19 Genotype Predictor of Gastric Acid Suppression

Early Phase 1

Withdrawn

Conditions: Esophagitis

Interventions: Drug: Omeprazole

First Posted Date: 2013-04-04

Last Posted Date: 2017-10-11

Lead Sponsor: Mayo Clinic

Registration Number: NCT01824199

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Muscle Protein Metabolism in Obesity

Phase 1

Completed

Conditions: Obesity

Interventions: Other: Increase in the levels of plasma amino acids
Other: Aerobic exercise

First Posted Date: 2013-04-04

Last Posted Date: 2020-04-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 84

Registration Number: NCT01824173

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Second Echelon Node Study With Methylene Blue

Not Applicable

Completed

Conditions: Melanoma
Breast Cancer

Interventions: Procedure: Methylene blue dye injection of sentinel lymph node

First Posted Date: 2013-04-04

Last Posted Date: 2018-03-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 21

Registration Number: NCT01823172

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy